会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明专利
    • New cyclic peptide
    • 新循环肽
    • JP2003064094A
    • 2003-03-05
    • JP2001295045
    • 2001-08-23
    • Chemgenesis IncTakashi TakahashiTokyo Kasei Kogyo Kk東京化成工業株式会社株式会社ケムジェネシス孝志 高橋
    • TAKAHASHI TAKASHIDOI TAKAYUKISHIMAZU SAYAKA
    • A61K38/55A61P31/14A61P43/00C07B61/00C07K1/113C07K5/02
    • PROBLEM TO BE SOLVED: To solve the problem that the conformation of a cyclic peptide is urgently required to be restricted and fixed because the cyclic peptide is known to have various kinds of bioactivities exemplified by that as a protease inhibitor, and has a possibility that the cyclic peptide mimicking the β-turn structure becomes the protease inhibitor, but the conformation of the cyclic peptide has a wide freedom, and looses the three-dimensional structure especially in an aqueous solution, to cause the case in which the expected protease inhibiting ability is not exhibited. SOLUTION: This cyclic peptide is obtained by introducing an aromatic ring and two carbonyl groups to the cyclic peptide to restrict and fix the conformation of the cyclic peptide. Various kinds of the conformations become possible by changing the aromatic ring. As a result, various kinds of the bioactive cyclic peptide can be provided.
    • 要解决的问题为了解决环状肽的构象迫切需要限制和固定的问题,因为已知环状肽具有例如作为蛋白酶抑制剂的各种生物活性,并且具有以下可能性: 模拟β-转角结构的环状肽成为蛋白酶抑制剂,但是环状肽的构象具有宽的自由度,特别是在水溶液中失去三维结构,导致预期的蛋白酶抑制能力为 没有展出。 解决方案:通过向环状肽引入芳环和两个羰基来限制和固定环肽的构象,获得该环肽。 通过改变芳环可以使各种构象变得可能。 结果,可以提供各种生物活性环肽。